Dr Reddy’s Gets Ad­verse Rul­ing in US in Pa­tent Case

The Economic Times - - Companies: Pursuit Of Profit -

Drug ma­jor Dr Reddy’s Lab­o­ra­to­ries on Thurs­day said it has re­ceived an un­favourable rul­ing in a US court re­gard­ing a pa­tent in­fringe­ment case over anti-nau­sea in­jec­tion Aloxi. In a BSE fil­ing, Reddy’s Labs said: “The court found that Dr Reddy’s pro­posed palonosetron hy­drochlo­ride 0.25 mg/5 ml in­fringes on cer­tain claims of US patents...and that the as­serted claims were not valid.”

NEW DELHI

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.